Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results‐Medicare analysis of 5235 patients

Abstract Background Gastroenteropancreatic neuroendocrine tumors (GEP‐NETs) are increasingly common malignancies and tend to have favorable long‐term prognoses. Somatostatin analogues (SSA) are a first‐line treatment for many NETs. Short‐term experiments suggest an association between SSAs and hyper...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Katherine Ni, Jeong Yun Yang, Kiwoon Baeg, Amanda C. Leiter, Grace Mhango, Emily J. Gallagher, Juan P. Wisnivesky, Michelle K. Kim
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-10-01
coleção:	Cancer Reports
Assuntos:	cancer survivorship digestive cancer epidemiology neuroendocrine tumor SEER somatostatin analogue
Acesso em linha:	https://doi.org/10.1002/cnr2.1387
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!